Literatur
-
01
Block GA .
Spiegel DM .
Ehrlich J .
et al .
Effects of Sevelamer and calcium on coronary artery calcification in hemodialysis patients.
Kidney Int.
2005;
68
1815-1824
-
02
Block GA .
Raggi P .
Bellasi A .
et al .
Mortality effect of coronary calcification and phosphat binder choice in incident hemodialysis patients.
Kidney Int.
2007;
71
438-441
-
03
Chertow GM .
Burke SK .
Raggi P .
et al .
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients.
Kidney Int.
2002;
62
245-252
-
04
London GM .
Marty C .
Marchais SJ .
Arterial calcifications and bone histomorphometry in end-stage renal disease.
J Am Soc Nephrol.
204;
15
1943-1953
-
05
Moe S .
Drüeke T .
Cunningham J .
et al .
Definition, evaluation, and calcification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).
Kidney Int.
2006;
69
1945-1953
-
06
Raggi P .
Bellasi A .
Ferramosca E .
et al .
Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients.
Hypertension.
2007;
49
1278-1284
-
07
Schultz E .
Arfai K .
Liu X .
et al .
Aortic calcification and the risk of osteoporosis and fractures.
J Clin Endocrinol Metab.
2004;
89
4246-4253
-
08
St. Peter W .
J Liu J .
Fan Q .
Weinhandl E .
DCOR Study. Assessing impact of sevelamer vs calcium binders on hospitalization and morbidity in hemodialysis patients using CMS data.
ASN.
2006;
01 Renagel In New Dialysis
02 Kidney Disease: Improving Global Outcome
